Search
Close this search box.

A randomised, placebo-controlled, double-blind study of adjuvant Cemiplimab versus placebo after surgery and radiation therapy in patients with high risk cutaneous squamous cell carcinoma

Primary Sponsor

Collaborating Groups

TROG Cancer Research

Trial Chairperson

Prof Sandro Porceddu - Princess Alexandra Hospital

Trial Contact

qa@trog.com.au

Related Post

October 18, 2022

NINJA Radiation Therapy Trial participant tells his journey to treatment

The journey to becoming the 200th participant for the

September 6, 2022

The gift that kept on giving

The NewyWay Coffee Collaboration Newcastle marketing agency, The Marketing